トップ > 販売中止製品一覧
製品タイプ（9890）
| Code No. | 製品名 | 販売中止日 | メーカー |
|---|---|---|---|
| B-AM2365M | Anti-CD34 (Endothelial Cell) mAb | 2020/03/31 | BIOGENEX |
| B-AM2395M | Anti-p53 Protein mAb | 2020/03/31 | BIOGENEX |
| B-AM2405M | Anti-p53 Protein mAb | 2020/03/31 | BIOGENEX |
| B-AM2415M | Anti-CD31 (PECAM-1) mAb | 2020/03/31 | BIOGENEX |
| B-AM2445M | Anti-Dystrophin mAb | 2020/03/31 | BIOGENEX |
| B-AM2525M | Anti-PCNA mAb | 2020/03/31 | BIOGENEX |
| B-AM2545M | Anti-Cytomegalovirus mAb | 2020/03/31 | BIOGENEX |
| B-AM2615M | Anti-CD8 mAb | 2020/03/31 | BIOGENEX |
| B-AM2685M | Anti-CD56 (Natural Killer Cell, NCAM) mAb | 2020/03/31 | BIOGENEX |
| B-AM2875M | Anti-Bcl-2 Oncoprotein mAb | 2020/03/31 | BIOGENEX |
| B-AM2915M | Anti-Cytokeratin High MW mAb | 2020/03/31 | BIOGENEX |
| B-AM2985M | Anti-CD29 mAb | 2020/03/31 | BIOGENEX |
| B-AM3055M | Anti-CD43 (T cell, Leukosialin) mAb | 2020/03/31 | BIOGENEX |
| B-AM3105M | Anti-CD44 mAb | 2020/03/31 | BIOGENEX |
| B-AM3145M | Anti-CD57 (Natural Killer Cell) mAb | 2020/03/31 | BIOGENEX |
| B-AM3185M | Anti-c-myc Protein mAb | 2020/03/31 | BIOGENEX |
| B-AM3255M | Anti-CD66 mAb | 2020/03/31 | BIOGENEX |
| B-AM3325M | Anti-Caldesmon, High MW, Smooth Muscle mAb | 2020/03/31 | BIOGENEX |
| B-AM3335M | Anti-Calponin mAb | 2020/03/31 | BIOGENEX |
| B-AM3375M | Anti-Factor XIII Subunit A mAb | 2020/03/31 | BIOGENEX |
| B-AM3545M | Anti-CD71 (Transferrin Receptor) mAb | 2020/03/31 | BIOGENEX |
| B-AM3585M | Anti-Mucin-2 (MUC-2) mAb | 2020/03/31 | BIOGENEX |
| B-AM3595M | Anti-bFGF mAb | 2020/03/31 | BIOGENEX |
| B-AM3625ME | Anti-HPV16 mAb | 2020/03/31 | BIOGENEX |
| B-AM3635M | Anti-Synaptophysin mAb | 2020/03/31 | BIOGENEX |
| B-AM3795M | Anti-Collagen IV mAb | 2020/03/31 | BIOGENEX |
| B-AM3905M | Anti-E-Cadherin mAb | 2020/03/31 | BIOGENEX |
| B-AM3915M | Anti-P-Glycoprotein mAb | 2020/03/31 | BIOGENEX |
| B-AM3925M | Anti-CDX-2 mAb | 2020/03/31 | BIOGENEX |
| B-AM4185M | Anti-p63 mAb | 2020/03/31 | BIOGENEX |
| B-AM4215M | Anti-CD4 mAb | 2020/03/31 | BIOGENEX |
| B-AM4235M | Anti-CD117 mAb | 2020/03/31 | BIOGENEX |
| B-AM4305M | Anti-CD5 mAb | 2020/03/31 | BIOGENEX |
| B-AM4315M | Anti-CD35 mAb | 2020/03/31 | BIOGENEX |
| B-AM4325M | Anti-Myf-4 mAb | 2020/03/31 | BIOGENEX |
| B-AM4335M | Anti-Mesothelin mAb | 2020/03/31 | BIOGENEX |
| B-AM4555M | Anti-MUC4 mAb | 2020/03/31 | BIOGENEX |
| B-AM4565M | Anti-MUC5AC mAb | 2020/03/31 | BIOGENEX |
| B-AM4595M | Anti-Tau mAb | 2020/03/31 | BIOGENEX |
| B-AM4875M | Anti-ACTH mAb | 2020/03/31 | BIOGENEX |
| B-AM4905M | Anti-CD1a mAb | 2020/03/31 | BIOGENEX |
| B-AM5055M | Anti-GLUT-1 mAb | 2020/03/31 | BIOGENEX |
| B-AM5295M | Anti-TIA-1 mAb | 2020/03/31 | BIOGENEX |
| B-AM5345M | Anti-CD227 (MUCIN 1) mAb | 2020/03/31 | BIOGENEX |
| B-AM5395M | Anti-Glypican-3 mAb | 2020/03/31 | BIOGENEX |
| B-AM5405M | Anti-p16 (INK4a) mAb | 2020/03/31 | BIOGENEX |
| B-AM5435M | Anti-Renal Cell Carcinoma (RCC) mAb | 2020/03/31 | BIOGENEX |
| B-AM5705M | Anti-DOG1 mAb | 2020/03/31 | BIOGENEX |
| B-AM5835M | Anti-Calretinin mAb | 2020/03/31 | BIOGENEX |
| B-AM7015M | Anti-Napsin A mAb | 2020/03/31 | BIOGENEX |
| B-AM7025M | Anti-CD7 mAb | 2020/03/31 | BIOGENEX |
| B-AM7035M | Anti-MLH1 mAb | 2020/03/31 | BIOGENEX |
| B-AN4495M | Anti-P504S (AMACR) mAb | 2020/03/31 | BIOGENEX |
| B-AN5385M | Anti-P504S (AMACR) mAb | 2020/03/31 | BIOGENEX |
| B-AR0215R | Anti-Hemoglobin A pAb | 2020/03/31 | BIOGENEX |
| B-AR0405R | Anti-Placental Lactogen pAb | 2020/03/31 | BIOGENEX |
| B-AR1255R | Anti-Toxoplasma gondii pAb | 2020/03/31 | BIOGENEX |
| B-AR4835R | Anti-VEGF pAb | 2020/03/31 | BIOGENEX |
| B-AR4965R | Anti-Myeloperoxidase (MPO) pAb | 2020/03/31 | BIOGENEX |
| B-MU001AUC | Anti-Melanoma mAb | 2020/03/31 | BIOGENEX |
| B-MU109UC | Anti-Myosin, Skeletal Muscle mAb | 2020/03/31 | BIOGENEX |
| B-MU122UC | Anti-Beta-Tubulin mAb | 2020/03/31 | BIOGENEX |
| B-MU133UC | Anti-Cytokeratin High MW mAb | 2020/03/31 | BIOGENEX |
| B-MU146UC | Anti-Cytokeratin 14 mAb | 2020/03/31 | BIOGENEX |
| B-MU167UC | Anti-Collagen III mAb | 2020/03/31 | BIOGENEX |
| B-MU178UC | Anti-Beta-Tubulin IV mAb | 2020/03/31 | BIOGENEX |
| B-MU195UC | Anti-p53 Protein mAb | 2020/03/31 | BIOGENEX |
| B-MU213UC | Anti-Mitochondrial Antigen mAb | 2020/03/31 | BIOGENEX |
| B-MU231UC | Anti-BLA36 mAb | 2020/03/31 | BIOGENEX |
| B-MU239UC | Anti-p53 Protein mAb | 2020/03/31 | BIOGENEX |
| B-MU240UC | Anti-p53 Protein mAb | 2020/03/31 | BIOGENEX |
| B-MU241UC | Anti-CD31 (PECAM-1) mAb | 2020/03/31 | BIOGENEX |
| B-MU254UC | Anti-Cytomegalovirus mAb | 2020/03/31 | BIOGENEX |
| B-MU256UCE | Anti-Androgen Receptor mAb | 2020/03/31 | BIOGENEX |
| B-MU302UC | Anti-CD15 mAb | 2020/03/31 | BIOGENEX |
| B-MU333UC | Anti-Calponin mAb | 2020/03/31 | BIOGENEX |
| B-MU336UC | Anti-GLEPP-1mAb | 2020/03/31 | BIOGENEX |
| B-MU337UC | Anti-Factor XIII Subunit A mAb | 2020/03/31 | BIOGENEX |
| B-MU354UC | Anti-CD71 (Transferrin Receptor) mAb | 2020/03/31 | BIOGENEX |
| B-MU355UC | Anti-CD99 (MIC2 Antigen) mAb | 2020/03/31 | BIOGENEX |
| B-MU358UC | Anti-Mucin-2 (MUC-2) mAb | 2020/03/31 | BIOGENEX |
| B-MU361UC | Anti-Melan-A (MART-1) mAb | 2020/03/31 | BIOGENEX |
| B-MU363UC | Anti-Synaptophysin mAb | 2020/03/31 | BIOGENEX |
| B-MU374UC | Anti-J Chain mAb | 2020/03/31 | BIOGENEX |
| B-MU377UC | Anti-TGF alpha mAb | 2020/03/31 | BIOGENEX |
| B-MU390UC | Anti-E-Cadherin mAb | 2020/03/31 | BIOGENEX |
| B-MU392AUC | Anti-CDX-2 mAb | 2020/03/31 | BIOGENEX |
| B-MU410UC | Anti-Ki67 mAb | 2020/03/31 | BIOGENEX |
| B-MU416UC | Anti-CD68 mAb | 2020/03/31 | BIOGENEX |
| B-MU418UC | Anti-p63 mAb | 2020/03/31 | BIOGENEX |
| B-MU421UC | Anti-CD4 mAb | 2020/03/31 | BIOGENEX |
| B-MU429UC | Anti-CA125 mAb | 2020/03/31 | BIOGENEX |
| B-MU430UC | Anti-CD5 mAb | 2020/03/31 | BIOGENEX |
| B-MU432UC | Anti-Myf-4 mAb | 2020/03/31 | BIOGENEX |
| B-MU434UC | Anti-p21/WAF1 mAb | 2020/03/31 | BIOGENEX |
| B-MU439UC | Anti-CD22 mAb | 2020/03/31 | BIOGENEX |
| B-MU455UC | Anti-MUC4 mAb | 2020/03/31 | BIOGENEX |
| B-MU456UC | Anti-MUC5AC mAb | 2020/03/31 | BIOGENEX |
| B-MU490UC | Anti-CD1a mAb | 2020/03/31 | BIOGENEX |
| B-MU505UC | Anti-GLUT-1 mAb | 2020/03/31 | BIOGENEX |